Merit Medical Systems Inc
A maker of single-use medical devices for cardiology, radiology, oncology, and endoscopy, Merit Medical sells products like the SCOUT radar localization system, Wrapsody endoprosthesis, and C2 CryoBalloon. It was founded in 1987 in a Murray, Utah industrial park to replace fragile hospital glass syringes with a safer disposable plastic syringe—the name "Merit" reflects its performance-driven culture.
Bought 2.0K
Bought 1.5K
Granted 24.7K
Bought 2.0K
Bought 2.3K
Granted 3.5K
Bought 1.6K
Granted 3.5K
Sold 7.5K
Granted 3.5K
Granted 3.5K · Sold 5.0K
Granted 3.5K
Granted 3.5K
Granted 3.5K
Granted 3.5K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY · 2 transactions | — | 62.1K | — | 2.0K | — |
| Parra Raul Jr.CFO AND TREASURER · 1 transaction | +2.4% | 61.5K | — | 1.5K | — |
| Gunderson Thomas J.Director · 3 transactions | — | 60.7K | 24.7K | — | — |
| Aronson Martha GoldbergPresident and CEO, Director · 1 transaction | +4.2% | 49.8K | — | 2.0K | — |
| Voigt Michel J.CHIEF HUMAN RESOURCES OFFICER · 3 transactions | +62% | 47.7K | — | 2.3K | — |
| Millner F. Ann Ed.D.Director · 1 transaction | — | 38.0K | 3.5K | — | — |
| Smith Christian AdamChief Commercial Officer · 1 transaction | +64.9% | 32.6K | — | 1.6K | — |
| Carpenter Lonny J.Director · 1 transaction | — | 20.8K | 3.5K | — | — |
| Peterson Neil W.CHIEF OPERATING OFFICER · 1 transaction | -49.9% | 18.1K | — | — | 7.5K |
| Kaiser Laura S.Director · 1 transaction | +34.9% | 13.4K | 3.5K | — | — |
| Ward Lynne N.Director · 2 transactions | -12% | 11.3K | 3.5K | — | 5.0K |
| Evans Stephen C.Director · 1 transaction | +50.8% | 10.3K | 3.5K | — | — |
| McDonnell Michael R.Director · 1 transaction | +54.1% | 9.9K | 3.5K | — | — |
| Perez Silvia M.Director · 1 transaction | — | 8.0K | 3.5K | — | — |
| Ward Scott R.Director · 1 transaction | — | 3.5K | 3.5K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -3.1K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.